Organism name | Brassica napus |
---|---|
Genus | Brassica |
Family | Cruciferae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Brassica napus |
---|---|
Linked NCBI taxonomy ID | 3708 |
Linked level | species |
Family in NCBI taxonomy | Brassicaceae |
---|---|
ID | 3700 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005557
![]() |
Isorhamnetin 3-glucoside-7-rhamnoside
/ Isorhamnetin 3-O-beta-glucopyranoside-7-O-alpha-rhamnopyranoside |
No. 1 | No. 15 |
![]() |
||||
C00005548
![]() |
Narcissin
/ Isorhamnetin 3-O-rutinoside |
CHEMBL84174
CHEMBL258394 CHEMBL1711509 CHEMBL2165403 |
C031062
|
7 / 1 / 2 | No. 1 | No. 15 |
![]() |
|
C00005579
![]() |
Isorhamnetin 3-sophoroside-7-glucoside
|
No. 5 | No. 15 |
![]() |
||||
C00005916
![]() |
Kaempferol 3-(2'''-sinapylsophoroside)-7-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00005922
![]() |
Kaempferol 3-(2''-sinapylglucoside)-7-sophoroside
|
No. 7 | No. 15 |
![]() |
||||
C00000029
![]() |
GA29
/ Gibberellin A29 |
No. 40 | No. 41 |
![]() |
||||
C00000008
![]() |
GA8
/ Gibberellin A8 |
No. 40 | No. 41 |
![]() |
||||
C00000003
![]() |
GA3
/ Gibberellin A3 |
CHEMBL513241
CHEMBL566653 CHEMBL1232952 CHEMBL1476967 CHEMBL1487394 |
C007842
|
10 / 18 / 17 | No. 40 | No. 41 |
![]() |
|
C00000004
![]() |
GA4
/ Gibberellin A4 |
No. 40 | No. 41 |
![]() |
||||
C00000034
![]() |
GA34
/ Gibberellin A34 |
No. 40 | No. 41 |
![]() |
||||
C00000044
![]() |
GA44
/ Gibberellin A44 |
No. 40 | No. 41 |
![]() |
||||
C00000051
![]() |
GA51
/ Gibberellin A51 |
No. 40 | No. 41 |
![]() |
||||
C00000015
![]() |
GA15
/ Gibberellin A15 |
No. 40 | No. 41 |
![]() |
||||
C00000020
![]() |
GA20
/ Gibberellin A20 |
No. 40 | No. 41 |
![]() |
||||
C00000001
![]() |
GA1
/ Gibberellin A1 |
C422660
|
No. 40 | No. 41 |
![]() |
|||
C00001463
![]() |
Glucobrassicanapin
/ 4-Pentenyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00003646
![]() |
Brassicasterol
/ (24R)24-Methylcholest-5,22-dien-3beta-ol |
CHEMBL1836652
|
C003532
|
No. 53 | No. 11 |
![]() |
||
C00003647
![]() |
Campesterol
/ 24alpha-Methylcholesterol / (24R)24-Methylcholest-5-en-3beta-ol |
CHEMBL520535
CHEMBL485421 CHEMBL1836653 |
C021273
|
No. 53 | No. 11 |
![]() |
||
C00000176
![]() |
Brassinolide
|
CHEMBL563853
CHEMBL1801925 CHEMBL1967970 |
C023623
|
16 / 2 | No. 68 | No. 11 |
![]() |
|
C00000911
![]() |
Lycopene
/ all-trans-Lycopene |
CHEMBL501174
CHEMBL1984187 |
C015329
|
6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |
![]() |
C00000125
![]() |
Glucobrassicin
/ Glucobrassicine / 3-Indolylmethylglucosinolate |
C048308
|
2 / 0 | No. 158 | No. 77 |
![]() |
||
C00000128
![]() |
4-Methoxyglucobrassicin
/ 4-Methoxy-3-indolylmethylglucosinolate |
C036025
|
No. 158 | No. 77 |
![]() |
|||
C00000127
![]() |
4-Hydroxyglucobrassicin
/ 4-Hydroxy-3-indolylmethylglucosinolate |
C036021
|
No. 158 | No. 77 |
![]() |
|||
C00000126
![]() |
Neoglucobrassicin
/ 1-Methoxy-3-indolylmethylglucosinolate |
C064701
|
2 / 0 | No. 158 | No. 77 |
![]() |
||
C00001230
![]() |
Nervonic acid
|
C013147
|
No. 184 | No. 68 |
![]() |
|||
C00000017
![]() |
GA17
/ Gibberellin A17 |
No. 187 | No. 41 |
![]() |
||||
C00000053
![]() |
GA53
/ Gibberellin A53 |
No. 187 | No. 41 |
![]() |
||||
C00000019
![]() |
GA19
/ Gibberellin A19 |
C120175
|
No. 187 | No. 41 |
![]() |
|||
C00000218
![]() |
Jasmonic acid
/ trans-Jasmonic acid / 3-Oxo-2-(2Z-pentenyl)cyclotentylacetic acid |
CHEMBL445499
CHEMBL449572 |
C011006
|
4 / 1 / 0 | No. 707 | No. 70 |
![]() |
|
C00000356
![]() |
cis-3-Hexen-1-ol
|
C051918
|
0 / 1 | No. 1746 |
![]() |
|||
C00033745
![]() |
Cyclobrassinin
|
No. 3628 |
![]() |
|||||
C00001546
![]() |
Methoxybrassinin
/ 1-Methoxybrassinin |
No. 3839 |
![]() |
|||||
C00007609
![]() |
4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate
|
No. 5373 |
![]() |
|||||
C00007608
![]() |
4-Metyl-5-(beta-hydroxyethyl)thiazole phosphate
|
No. 6773 | No. 5 |
![]() |
||||
C00007610
![]() |
4-methyl-5-(2hydroxyethyl)thiazole
/ 4-Metyl-5-(beta-hydroxyethyl)thiazole |
CHEMBL1236482
|
C012572
|
No. 7034 | No. 5 |
![]() |
||
C00007392
![]() |
Acetaldehyde
/ Acetic aldehyde |
CHEMBL170365
|
D000079
|
2 / 8 / 5 | 126 / 15 | No. 7289 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O75496 | Geminin | Unclassified protein | C00000003 C00000911 C00005548 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000003 C00005548 | 0 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00000003 C00000911 | 11 / 10 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000003 | 0 / 1 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005548 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000911 | 2 / 3 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000218 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000003 | 2 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000003 | 1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00005548 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000003 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00007392 | 3 / 2 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00007392 | 5 / 3 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000003 | 0 / 0 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000218 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00005548 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00005548 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000003 | 1 / 1 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000218 | 1 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00005548 | 0 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000218 | 1 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000003 | 3 / 4 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000911 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
847 | CAT | catalase (EC:1.11.1.6) |
C00000911
C00007392
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000176
C00007392
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000176
C00007392
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000176
C00000911
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000911
C00007392
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00000911
C00007392
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000176
C00000911
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000911
C00007392
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000911
C00007392
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000911
C00007392
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000176
C00000911
|
898 | CCNE1, CCNE | cyclin E1 |
C00000176
C00000911
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000911
C00007392
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000176
C00000911
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000176
C00000911
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000176
C00000911
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000176
C00000911
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00007392
|
1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) |
C00000911
|
1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) |
C00000911
|
23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) |
C00000911
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000911
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00000911
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00000911
|
1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00000911
|
2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00000911
|
2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00000911
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000911
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa |
C00000911
|
2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa |
C00000911
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00000911
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00000911
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000911
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00000911
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00000911
|
3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa |
C00000911
|
3713 | IVL | involucrin |
C00000911
|
3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00000911
|
118 | ADD1, ADDA | adducin 1 (alpha) |
C00000911
|
3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A |
C00000911
|
3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00000911
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000911
|
3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
C00000911
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000911
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000911
|
6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00000911
|
5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00000911
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00000911
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000911
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00000911
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00000911
|
100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A |
C00000911
|
4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00000911
|
4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00000911
|
2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 |
C00000911
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000911
|
8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa |
C00000911
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00000911
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00000911
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00000911
|
8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
C00000911
|
8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) |
C00000911
|
5962 | RDX, DFNB24 | radixin |
C00000911
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00000911
|
6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00000911
|
6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00000911
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000911
|
6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 |
C00000911
|
571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00000911
|
8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00000911
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00000911
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00000911
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00000911
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00000911
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000911
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000911
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000911
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000911
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000911
|
7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00000911
|
7485 | WRB, CHD5 | tryptophan rich basic protein |
C00000911
|
7697 | ZNF138, pHZ-32 | zinc finger protein 138 |
C00000911
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000911
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00000176
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00000176
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000911
|
891 | CCNB1, CCNB | cyclin B1 |
C00000176
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00000176
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000176
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00000176
|
2877 | GPX2, GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI, GSHPx-2 | glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
C00000125
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000125
|
3251 | HPRT1, HGPRT, HPRT | hypoxanthine phosphoribosyltransferase 1 (EC:2.4.2.8) |
C00000126
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000126
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00007392
|
43 | ACHE, ACEE, ARACHE, N-ACHE, YT | acetylcholinesterase (EC:3.1.1.7) |
C00007392
|
125 | ADH1B, ADH2 | alcohol dehydrogenase 1B (class I), beta polypeptide (EC:1.1.1.1) |
C00007392
|
126 | ADH1C, ADH3 | alcohol dehydrogenase 1C (class I), gamma polypeptide (EC:1.1.1.1) |
C00007392
|
127 | ADH4, ADH-2 | alcohol dehydrogenase 4 (class II), pi polypeptide (EC:1.1.1.1) |
C00007392
|
9370 | ADIPOQ, ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28 | adiponectin, C1Q and collagen domain containing |
C00007392
|
216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) |
C00007392
|
219 | ALDH1B1, ALDH5, ALDHX | aldehyde dehydrogenase 1 family, member B1 (EC:1.2.1.3) |
C00007392
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00007392
|
218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00007392
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00007392
|
223 | ALDH9A1, ALDH4, ALDH7, ALDH9, E3, TMABADH | aldehyde dehydrogenase 9 family, member A1 (EC:1.2.1.3 1.2.1.19 1.2.1.47) |
C00007392
|
57679 | ALS2, ALS2CR6, ALSJ, IAHSP, PLSJ | amyotrophic lateral sclerosis 2 (juvenile) |
C00007392
|
221079 | ARL5B, ARL8 | ADP-ribosylation factor-like 5B |
C00007392
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00007392
|
8553 | BHLHE40, BHLHB2, DEC1, HLHB2, SHARP-2, STRA13, Stra14 | basic helix-loop-helix family, member e40 |
C00007392
|
283687 | C15orf37 | chromosome 15 open reading frame 37 |
C00007392
|
57035 | C1orf63, DJ465N24.2.1, NPD014, RP3-465N24.4 | chromosome 1 open reading frame 63 |
C00007392
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00007392
|
57018 | CCNL1, ANIA6A, PRO1073, ania-6a | cyclin L1 |
C00007392
|
729230 | CCR2, CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R | chemokine (C-C motif) receptor 2 |
C00007392
|
1081 | CGA, CG-ALPHA, FSHA, GPHA1, GPHa, HCG, LHA, TSHA | glycoprotein hormones, alpha polypeptide |
C00007392
|
1268 | CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR | cannabinoid receptor 1 (brain) |
C00007392
|
728577 | CNTNAP3B | contactin associated protein-like 3B |
C00007392
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00007392
|
1278 | COL1A2, OI4 | collagen, type I, alpha 2 |
C00007392
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00007392
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00007392
|
64651 | CSRNP1, AXUD1, CSRNP-1, FAM130B, TAIP-3, URAX1 | cysteine-serine-rich nuclear protein 1 |
C00007392
|
1536 | CYBB, AMCBX2, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX | cytochrome b-245, beta polypeptide |
C00007392
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00007392
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00007392
|
22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00007392
|
1850 | DUSP8, C11orf81, HB5, HVH-5, HVH8 | dual specificity phosphatase 8 (EC:3.1.3.16 3.1.3.48) |
C00007392
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00007392
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00007392
|
1974 | EIF4A2, BM-010, DDX2B, EIF4A, EIF4F, eIF-4A-II, eIF4A-II | eukaryotic translation initiation factor 4A2 (EC:3.6.4.13) |
C00007392
|
1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00007392
|
2177 | FANCD2, FA-D2, FA4, FACD, FAD, FAD2, FANCD | Fanconi anemia, complementation group D2 |
C00007392
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00007392
|
94234 | FOXQ1, HFH1 | forkhead box Q1 |
C00007392
|
2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00007392
|
100702724 |
C00007392
|
||
2669 | GEM, KIR | GTP binding protein overexpressed in skeletal muscle |
C00007392
|
2741 | GLRA1, HKPX1, STHE | glycine receptor, alpha 1 |
C00007392
|
57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide |
C00007392
|
3280 | HES1, HES-1, HHL, HRY, bHLHb39 | hes family bHLH transcription factor 1 |
C00007392
|
29923 | HILPDA, C7orf68, HIG-2, HIG2 | hypoxia inducible lipid droplet-associated |
C00007392
|
554219 |
C00007392
|
||
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00007392
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00007392
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00007392
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00007392
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00007392
|
3708 | ITPR1, INSP3R1, IP3R, IP3R1, SCA15, SCA16, SCA29 | inositol 1,4,5-trisphosphate receptor, type 1 |
C00007392
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00007392
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00007392
|
4144 | MAT2A, MATA2, MATII, SAMS2 | methionine adenosyltransferase II, alpha (EC:2.5.1.6) |
C00007392
|
153364 | MBLAC2 | metallo-beta-lactamase domain containing 2 |
C00007392
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00007392
|
84981 | MIR22HG, C17orf91 | MIR22 host gene (non-protein coding) |
C00007392
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00007392
|
4320 | MMP11, SL-3, ST3, STMY3 | matrix metallopeptidase 11 (stromelysin 3) (EC:3.4.24.-) |
C00007392
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00007392
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00007392
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00007392
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00007392
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00007392
|
4791 | NFKB2, H2TF1, LYT-10, LYT10, NF-kB2, p105, p52 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
C00007392
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00007392
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00007392
|
3164 | NR4A1, GFRP1, HMR, N10, NAK-1, NGFIB, NP10, NUR77, TR3 | nuclear receptor subfamily 4, group A, member 1 |
C00007392
|
4929 | NR4A2, HZF-3, NOT, NURR1, RNR1, TINUR | nuclear receptor subfamily 4, group A, member 2 |
C00007392
|
424046 |
C00007392
|
||
100506658 | OCLN, BLCPMG | occludin (EC:2.1.1.67) |
C00007392
|
4953 | ODC1, ODC | ornithine decarboxylase 1 (EC:4.1.1.17) |
C00007392
|
23035 | PHLPP2, PHLPPL | PH domain and leucine rich repeat protein phosphatase 2 (EC:3.1.3.16) |
C00007392
|
57157 | PHTF2 | putative homeodomain transcription factor 2 |
C00007392
|
91461 | PKDCC, SGK493, Vlk | protein kinase domain containing, cytoplasmic |
C00007392
|
5335 | PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1 | phospholipase C, gamma 1 (EC:3.1.4.11) |
C00007392
|
55629 | PNRC2 | proline-rich nuclear receptor coactivator 2 |
C00007392
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00007392
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00007392
|
5514 | PPP1R10, CAT53, FB19, PNUTS, PP1R10, R111, p99 | protein phosphatase 1, regulatory subunit 10 |
C00007392
|
5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00007392
|
5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00007392
|
5581 | PRKCE, PKCE, nPKC-epsilon | protein kinase C, epsilon (EC:2.7.11.13) |
C00007392
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00007392
|
1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
51655 | RASD1, AGS1, DEXRAS1, MGC:26290 | RAS, dexamethasone-induced 1 |
C00007392
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00007392
|
5994 | RFXAP | regulatory factor X-associated protein |
C00007392
|
9886 | RHOBTB1 | Rho-related BTB domain containing 1 |
C00007392
|
27289 | RND1, ARHS, RHO6, RHOS | Rho family GTPase 1 |
C00007392
|
6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00007392
|
65117 | RSRC2 | arginine/serine-rich coiled-coil 2 |
C00007392
|
27111 | SDCBP2, SITAC, SITAC18, ST-2 | syndecan binding protein (syntenin) 2 |
C00007392
|
6403 | SELP, CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM, PSEL | selectin P (granule membrane protein 140kDa, antigen CD62) |
C00007392
|
54093 | SETD4, C21orf18, C21orf27 | SET domain containing 4 |
C00007392
|
84826 | SFT2D3 | SFT2 domain containing 3 |
C00007392
|
387640 | SKIDA1, C10orf140, DLN-1 | SKI/DACH domain containing 1 |
C00007392
|
6498 | SKIL, SNO, SnoA, SnoI, SnoN | SKI-like oncogene |
C00007392
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00007392
|
4089 | SMAD4, DPC4, JIP, MADH4, MYHRS | SMAD family member 4 |
C00007392
|
6667 | SP1 | Sp1 transcription factor |
C00007392
|
6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00007392
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00007392
|
56977 | STOX2 | storkhead box 2 |
C00007392
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00007392
|
7082 | TJP1, ZO-1 | tight junction protein 1 |
C00007392
|
22888 | UBOX5, RNF37, UBCE7IP5, UIP5 | U-box domain containing 5 |
C00007392
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00007392
|
10138 | YAF2 | YY1 associated factor 2 |
C00007392
|
56829 | ZC3HAV1, ARTD13, FLB6421, PARP13, ZAP, ZC3H2, ZC3HDC2 | zinc finger CCCH-type, antiviral 1 |
C00007392
|
7539 | ZFP37, ZNF906, zfp-37 | ZFP37 zinc finger protein |
C00007392
|
7769 | ZNF226 | zinc finger protein 226 |
C00007392
|
7310 |
C00007392
|
OMIM | preferred title | UniProt |
---|---|---|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
%606641 | Body mass index; bmi |
P37231
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#601665 | Obesity |
P37231
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D011471 | Prostatic Neoplasms |
C00000911
C00000176 |
D001249 | Asthma |
C00007392
|
D006965 | Hyperplasia |
C00000911
|
D007248 | Infertility, Male |
C00000911
|
D007249 | Inflammation |
C00000911
|
D007674 | Kidney Diseases |
C00000911
|
D009369 | Neoplasms |
C00000911
|
D020258 | Neurotoxicity Syndromes |
C00000911
|
D056486 | Drug-Induced Liver Injury |
C00000911
|
D012878 | Skin Neoplasms |
C00000911
|
D013733 | Testicular Diseases |
C00000911
|
D014178 | Translocation, Genetic |
C00000911
|
D015431 | Weight Loss |
C00000911
|
D001943 | Breast Neoplasms |
C00000176
|
D001008 | Anxiety Disorders |
C00000356
|
D006943 | Hyperglycemia |
C00000911
|
D002277 | Carcinoma |
C00007392
|
D002310 | Cardiomyopathy, Alcoholic |
C00007392
|
D005235 | Fatty Liver, Alcoholic |
C00007392
|
D006331 | Heart Diseases |
C00007392
|
D007022 | Hypotension |
C00007392
|
D007414 | Intestinal Neoplasms |
C00007392
|
D008175 | Lung Neoplasms |
C00007392
|
D015674 | Mammary Neoplasms, Animal |
C00007392
|
D009336 | Necrosis |
C00007392
|
D009421 | Nervous System Malformations |
C00007392
|
D011041 | Poisoning |
C00007392
|
D012220 | Rhinitis |
C00007392
|
D013274 | Stomach Neoplasms |
C00007392
|
D013610 | Tachycardia |
C00007392
|